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Timothy F. Kresowik, MD, Iowa City, Iowa
Dr. Nazarian and her colleagues have provided an elegant
statistical analysis of the carotid endarterectomy (CEA) volume/
outcome effect on mortality using a hospital administrative data-
base. Unfortunately, administrative databases are derived from
hospital claims which are focused on payment and are of only
limited utility for outcome studies. The capture of procedure
indication, comorbid conditions, and complications may be in-
complete or inaccurate. The inability to accurately stratify CEA
patients by indication or validly capture postoperative stroke is an
important limitation.
The striking finding that approximately half the surgeons
(214/442) in Maryland are performing one or fewer CEA proce-
dures a year is potentially more suggestive of a problem with the
database than necessarily an accurate representation of practice.
The database is derived from hospital claims not those of the
surgeon. The data field used to determine the physician of record
for the hospital stay could have non-surgeons (eg primary care
physicians or hospitalists) in that field. Acceptance of this finding
requires additional validation.
It is hard to argue against the concept that experience with agate for experience and even more importantly judgment. Is an-
nual volume as good a predictor for the surgeon who has had
adequate vascular training and practices 100% vascular surgery, but
with a relatively low volume of CEA procedures, as for the surgeon
without vascular training whose only vascular procedure is an
occasional CEA? These are important questions that are not an-
swered in this study.
I would argue that the perverse incentives associated with
using an annual procedure volume threshold alone to direct pay-
ment policy are likely to result in more harm than benefit. Over-
emphasis on procedure volume creates an incentive to do proce-
dures rather than counsel patients adequately about the risks versus
benefits of that procedure. In any study that has large numbers, it
is important to recognize that statistical significance does not
indicate the magnitude of the effect. In the current study, the
mortality of CEA for the group of surgeons who did four to 14
procedures a year was 0.7% versus 0.4% for the surgeons who did
15 or more. The benefit of carotid intervention in asymptomatic
patients is not high. Any policy that creates more incentive for the
potential overuse of carotid intervention in asymptomatic patients
is likely to cause more population harm than any benefit accrued
from this small absolute decrease in mortality.
